Pancragen and Tesamorelin Interaction

Monitor
Mechanism-based 47% confidence

Pancragen and Tesamorelin have an interaction requiring monitoring for interaction with 47% confidence. Both Pancragen and Tesamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). These compounds primarily affect different organ systems.

Compound Profiles

Pancragen

KEDW Tetrapeptide | Pancreas Bioregulator

Pancragen works through epigenetic regulation by interacting with chromatin complexes and DNA structures to modulate pancreatic gene expression. Research shows it upregulates critical transcription factors for pancreatic cell maturation including Pdx1, Pax6, Ptf1a, Foxa2, Nkx2.

Half-life: Not established Typical dose: 10-20mg daily longevity, metabolic
insulin disruptingteratogenic
View full profile

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Half-life: 26-38 minutes Typical dose: 1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) growth hormone, weight loss
ghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Pancreas
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (Pancragen, Tesamorelin). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (Pancragen, Tesamorelin). Monitor accordingly.

Frequently Asked Questions

Can I take Pancragen with Tesamorelin?

Yes, but with caution. Both Pancragen and Tesamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is Pancragen and Tesamorelin safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between Pancragen and Tesamorelin?

Both Pancragen and Tesamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Pancragen and Tesamorelin?

Pancragen has a half-life of Not established and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Pancragen vs Tesamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.